A<sub>2A</sub>R as a Prognostic Marker and a Potential Immunotherapy Target in Human Glioma
Gliomas are considered one of the most malignant tumors in the body. The immune system has the ability to control the initiation and development of tumors, including gliomas. Thus, immune cells find themselves controlled by various molecular pathways, inhibiting their activation, such as the immunos...
Main Authors: | Soumaya Rafii, Amina Ghouzlani, Oumayma Naji, Saadia Ait Ssi, Sarah Kandoussi, Abdelhakim Lakhdar, Abdallah Badou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/7/6688 |
Similar Items
-
NR2F6, a new immune checkpoint that acts as a potential biomarker of immunosuppression and contributes to poor clinical outcome in human glioma
by: Hayat Miftah, et al.
Published: (2023-07-01) -
Deciphering immune microenvironment and cell evasion mechanisms in human gliomas
by: Soumaya Rafii, et al.
Published: (2023-05-01) -
TMIGD2 as a potential therapeutic target in glioma patients
by: Chaimae Boulhen, et al.
Published: (2023-05-01) -
Gene Expression of GABA<sub>A</sub> Receptor Subunits and Association with Patient Survival in Glioma
by: Rafael Badalotti, et al.
Published: (2024-03-01) -
BTN3A: A Promising Immune Checkpoint for Cancer Prognosis and Treatment
by: Abdou-samad Kone, et al.
Published: (2022-11-01)